Literature DB >> 8871051

Modulation of T-cell cytokine secretion by accessory cell-derived products.

C M Hilkens1, A Snijders, F G Snijdewint, E A Wierenga, M L Kapsenberg.   

Abstract

Several major pathological characteristics of atopic disease are causally related to CD4+ allergen-specific type 2 T-helper (Th2) cells with an aberrant cytokine secretion profile, comprising high levels of interleukin (IL)-4 and IL-5 and low levels of interferon (IFN)-gamma. Although the cytokine secretion patterns of CD4+ T-cells may be stable, they can be modulated by physiological factors which may be expected to be present during activation of these T-cells. In this review, we will focus on two secretion products of professional antigen presenting cells (APCs) and accessory cells with opposite modulatory effects on T-cell cytokine profiles, i.e. prostaglandin E2 (PGE2) and IL-12. PGE2 favours Th2-like cytokine secretion profiles by inhibiting the production of the Th1-associated cytokines, IL-2 and IFN-gamma, and in the presence of sufficient levels of IL-2, upregulating the production of the Th2-associated cytokines, IL-4 and IL-5, IL-12, on the other hand, induces and enhances IFN-gamma secretion in activated CD4+ T-cells, thereby promoting the generation of Th1 cells. PGE2 and IL-12 act via independent mechanisms and, therefore, do not mutually interfere with their modulatory effects. These data suggest that the relative contribution of PGE2 and IL-12 to the levels of secreted Th1- and Th2-associated cytokines are determined by their concentration ratio during T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871051

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN: 0904-1850


  22 in total

Review 1.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Innate immunity and aging.

Authors:  Christian R Gomez; Vanessa Nomellini; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2008-06-11       Impact factor: 4.032

3.  Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.

Authors:  Natalie M Walker; Linda N Badri; Anish Wadhwa; Scott Wettlaufer; Marc Peters-Golden; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

Review 4.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

6.  Prostaglandins D2 and E2 have opposite effects on alveolar macrophages infected with Histoplasma capsulatum.

Authors:  Priscilla A T Pereira; Patrícia A Assis; Morgana K B Prado; Simone G Ramos; David M Aronoff; Francisco W G de Paula-Silva; Carlos A Sorgi; Lúcia H Faccioli
Journal:  J Lipid Res       Date:  2017-12-07       Impact factor: 5.922

7.  Characterization of prostaglandin E2 production by Candida albicans.

Authors:  John R Erb-Downward; Mairi C Noverr
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.

Authors:  Inger Vedin; Tommy Cederholm; Yvonne Freund-Levi; Hans Basun; Erik Hjorth; Gerd Faxén Irving; Maria Eriksdotter-Jönhagen; Marianne Schultzberg; Lars-Olof Wahlund; Jan Palmblad
Journal:  J Lipid Res       Date:  2009-11-24       Impact factor: 5.922

9.  Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

Authors:  Lamis Jarvinen; Linda Badri; Scott Wettlaufer; Takashi Ohtsuka; Theodore J Standiford; Galen B Toews; David J Pinsky; Marc Peters-Golden; Vibha N Lama
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention.

Authors:  Dayong Wu; Simin Nikbin Meydani
Journal:  J Leukoc Biol       Date:  2008-07-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.